Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Progress in the management of endometrial cancer (subtypes, immunotherapy, alterations in PIK3CA pathway): data and perspectives

(2020) Ana Oaknin et al.   CURRENT OPINION IN ONCOLOGY

Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes

(2018) Flora Nguyen Van Long et al.   Cancers

International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013

(2017) Joannie Lortet-Tieulent et al.   JNCI-Journal of the National Cancer Institute

International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013

(2017) Joannie Lortet-Tieulent et al.   JNCI-Journal of the National Cancer Institute

Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients

(2017) Virginie Marcel et al.   PLoS One

Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature

(2016) Maud-Emmanuelle Gilles et al.   CANCER RESEARCH

Regulation of nucleolin expression by miR-194, miR-206, and HuR

(2016) Sudeep Bose et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs

(2016) Jian-yu Xu et al.   TUMOR BIOLOGY

A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy

(2016) Chiara D’Avino et al.   Oncotarget

Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging

(2016) Nithya Subramanian et al.   Molecular Therapy-Nucleic Acids

AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin

(2016) Ye Cheng et al.   PLoS One

Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity

(2015) Jian-Yu Xu et al.   Asian Pacific Journal of Cancer Prevention

The roles of nucleolin subcellular localization in cancer

(2015) Caroline Madeleine Berger et al.   BIOCHIMIE

Human anti-nucleolin recombinant immunoagent for cancer therapy

(2015) Dario Palmieri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model

(2015) Elisabetta Benedetti et al.   Oncotarget

Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis

(2014) Won-Tak Choi et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy

(2014) XiaoDong Guo et al.   Diagnostic Pathology

Nucleolin identified by comparative mass-spectra analysis is a potential marker for invasive progression of hepatocellular carcinoma

(2014) BIN QIAN et al.   Molecular Medicine Reports

Cell Surface Nucleolin as a Target for Anti-Cancer Therapies

(2014) Marina Koutsioumpa et al.   Recent Patents on Anti-Cancer Drug Discovery

Cell surface nucleolin interacts with CXCR4 receptor via the 212 c-terminal portion

(2014) Hongxin Niu et al.   TUMOR BIOLOGY

Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer

(2013) Wensheng Qiu et al.   APMIS

Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex

(2013) J. F. Wise et al.   BLOOD

Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer

(2013) Hongyun Zhao et al.   PLoS One

Interactions of Nucleolin and Ribosomal Protein L26 (RPL26) in Translational Control of Human p53 mRNA

(2012) Jing Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice

(2012) Kouji Banno et al.   Epigenomics

A Simple Approach to Cancer Therapy Afforded by Multivalent Pseudopeptides That Target Cell-Surface Nucleoproteins

(2011) D. Destouches et al.   CANCER RESEARCH

Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs

(2011) Kotb Abdelmohsen et al.   NUCLEIC ACIDS RESEARCH

Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin

(2010) Bernard Krust et al.   BIOCHIMIE

Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin

(2008) Damien Destouches et al.   PLoS One